Suppr超能文献

多种重组HIV-1包膜蛋白无法激活表达广泛中和抗HIV-1抗体PG9和447-52D的种系B细胞受体的B细胞。

Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.

作者信息

McGuire Andrew T, Glenn Jolene A, Lippy Adriana, Stamatatos Leonidas

机构信息

Seattle Biomedical Research Institute, Seattle, Washington, USA.

出版信息

J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.

Abstract

UNLABELLED

Broadly neutralizing antibodies (bNAbs) against HIV-1 are generated during HIV-1-infection but have not yet been elicited by immunization with recombinant forms of the viral envelope glycoprotein (Env; the target of anti-HIV-1 neutralizing antibodies). A particular type of bNAb targets the CD4-binding site (CD4-BS) region of Env. These antibodies are derived from a limited number of VH/VL genes and can bind to and neutralize diverse HIV-1 strains. Recent reports have demonstrated the limited potential of Env to activate B cells expressing the germline B cell receptor (BCR) forms of anti-CD4-BS bNAbs. A potential reason for the lack of elicitation of anti-CD4-BS bNAbs by Env immunogens is the absence of stimulation of naive B cells expressing the germline BCRs of such antibodies. Several bNAbs have been isolated from HIV-1-infected subjects that target other structurally conserved regions of Env. How frequently Env immunogens stimulate the germline BCRs that give rise to bNAbs that target Env regions other than the CD4-BS is not well understood. Here, we investigated the interactions between diverse Envs and the BCRs of known bNAbs targeting not only the CD4-BS but also conserved elements of the second and third variable Env regions. Our results indicate that Env is generally ineffective in engaging germline BCRs of bNAbs irrespective of their epitope target. Potentially, this is the result of viral evolutionary mechanisms adopted to escape broadly neutralizing antibody responses. Our results also suggest that a single Env capable of activating germline BCRs that target distinct Env epitopes will be very difficult to identify or to design.

IMPORTANCE

Broadly neutralizing antibodies against HIV-1 are thought to be an important component of the immune responses that a successful vaccine should elicit. Broadly neutralizing antibodies are generated by a subset of those infected by HIV-1, but so far, they have not been generated by immunization with recombinant Envelope (Env, the target of anti-HIV-1 neutralizing antibodies). Here, we provide evidence that the inability of Env to elicit the production of broadly neutralizing antibodies is due to the inability of diverse Envs to engage the germline B cell receptor forms of known broadly neutralizing antibodies.

摘要

未标记

针对HIV-1的广泛中和抗体(bNAbs)在HIV-1感染期间产生,但尚未通过用病毒包膜糖蛋白(Env;抗HIV-1中和抗体的靶标)的重组形式进行免疫诱导产生。一种特定类型的bNAb靶向Env的CD4结合位点(CD4-BS)区域。这些抗体源自有限数量的VH/VL基因,能够结合并中和多种HIV-1毒株。最近的报告表明,Env激活表达抗CD4-BS bNAb的胚系B细胞受体(BCR)形式的B细胞的潜力有限。Env免疫原未能诱导抗CD4-BS bNAb产生的一个潜在原因是缺乏对表达此类抗体胚系BCR的幼稚B细胞的刺激。已经从HIV-1感染的受试者中分离出几种靶向Env其他结构保守区域的bNAb。Env免疫原刺激产生靶向除CD4-BS之外的Env区域的bNAb的胚系BCR的频率尚不清楚。在这里,我们研究了多种Env与已知bNAb的BCR之间的相互作用,这些bNAb不仅靶向CD4-BS,还靶向Env第二和第三可变区域的保守元件。我们的结果表明,无论其表位靶标如何,Env通常都无法有效地与bNAb的胚系BCR结合。这可能是病毒为逃避广泛中和抗体反应而采用的进化机制的结果。我们的结果还表明,很难鉴定或设计出一种能够激活靶向不同Env表位的胚系BCR的单一Env。

重要性

针对HIV-1的广泛中和抗体被认为是成功疫苗应诱导的免疫反应的重要组成部分。广泛中和抗体由一部分HIV-1感染者产生,但到目前为止,通过重组包膜(Env,抗HIV-1中和抗体的靶标)免疫尚未产生。在这里,我们提供证据表明,Env无法诱导产生广泛中和抗体是由于多种Env无法与已知广泛中和抗体的胚系B细胞受体形式结合。

相似文献

3
Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
PLoS Pathog. 2013 Jan;9(1):e1003106. doi: 10.1371/journal.ppat.1003106. Epub 2013 Jan 3.
4
5
B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques.
PLoS Pathog. 2018 Jun 22;14(6):e1007120. doi: 10.1371/journal.ppat.1007120. eCollection 2018 Jun.
7
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
PLoS Pathog. 2018 Nov 5;14(11):e1007431. doi: 10.1371/journal.ppat.1007431. eCollection 2018 Nov.
8
Anti-HIV B Cell lines as candidate vaccine biosensors.
J Immunol. 2012 Nov 15;189(10):4816-24. doi: 10.4049/jimmunol.1202165. Epub 2012 Oct 12.

引用本文的文献

1
Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-like antibodies.
PLoS Pathog. 2025 May 29;21(5):e1013039. doi: 10.1371/journal.ppat.1013039.
2
Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods.
Vaccines (Basel). 2025 Mar 12;13(3):304. doi: 10.3390/vaccines13030304.
3
Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-class antibodies.
bioRxiv. 2025 Mar 14:2025.03.13.642975. doi: 10.1101/2025.03.13.642975.
4
Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env.
J Virol. 2024 Oct 22;98(10):e0074424. doi: 10.1128/jvi.00744-24. Epub 2024 Sep 6.
5
Engaging an HIV vaccine target through the acquisition of low B cell affinity.
Nat Commun. 2023 Aug 28;14(1):5249. doi: 10.1038/s41467-023-40918-2.
7
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions.
Cell Rep Med. 2023 Apr 18;4(4):101003. doi: 10.1016/j.xcrm.2023.101003. Epub 2023 Apr 11.
8
Adjuvants influence the maturation of VRC01-like antibodies during immunization.
iScience. 2022 Nov 2;25(11):105473. doi: 10.1016/j.isci.2022.105473. eCollection 2022 Nov 18.
9
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike.
Nat Commun. 2022 Aug 4;13(1):4539. doi: 10.1038/s41467-022-32232-0.

本文引用的文献

2
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.
Nature. 2013 Apr 25;496(7446):469-76. doi: 10.1038/nature12053. Epub 2013 Apr 3.
3
Rational HIV immunogen design to target specific germline B cell receptors.
Science. 2013 May 10;340(6133):711-6. doi: 10.1126/science.1234150. Epub 2013 Mar 28.
5
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4351-6. doi: 10.1073/pnas.1217537110. Epub 2013 Feb 20.
6
Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.
PLoS Pathog. 2013 Jan;9(1):e1003106. doi: 10.1371/journal.ppat.1003106. Epub 2013 Jan 3.
8
2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.
J Virol. 2013 Feb;87(4):2234-41. doi: 10.1128/JVI.02820-12. Epub 2012 Dec 5.
9
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.
Nature. 2012 Nov 15;491(7424):406-12. doi: 10.1038/nature11544. Epub 2012 Sep 18.
10
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3268-77. doi: 10.1073/pnas.1217207109. Epub 2012 Oct 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验